- Double Mastectomy May Offer No Survival Benefit to Women With Breast Cancer
- Toxic Lead Found in Cinnamon Product, FDA Says
- Certain Abbott Blood Sugar Monitors May Give Incorrect Readings
- Athletes Can Expect High Ozone, Pollen Counts for Paris Olympics
- Fake Oxycontin Pills Widespread and Potentially Deadly: Report
- Shingles Vaccine Could Lower Dementia Risk
- Your Odds for Accidental Gun Death Rise Greatly in Certain States
- Kids From Poorer Families Less Likely to Survive Cancer
- Tough Workouts Won’t Trigger Cardiac Arrest in Folks With Long QT Syndrome
- At-Home Colon Cancer Test Can Save Lives
Drugs May Protect the Heart During Chemotherapy
![](https://ladylively.com/wp-content/uploads/2013/08/heart-cardio9-300x336.jpg)
Two kinds of medications can prevent heart damage in breast cancer patients as they undergo chemotherapy, a new study suggests.
Chemotherapy improves survival among women with early-stage breast cancer, but can dramatically increase their risk of heart failure, the researchers explained.
This five-year study of 100 early-stage breast cancer patients in Canada found that two kinds of heart medicines — beta blockers and ACE inhibitors — seem to protect the heart during chemotherapy.
“We think this is practice-changing. This will improve the safety of the cancer treatment that we provide,” study co-investigator Edith Pituskin, an assistant professor in the Faculty of Nursing and Faculty of Medicine and Dentistry at the University of Alberta in Canada, said in a university news release.
The heart medications not only protect the heart, but may also improve breast cancer patient survival rates by reducing the number of times chemotherapy needs to be interrupted, according to study leader Dr. Ian Paterson, a cardiologist at the Alberta Heart Institute and an associate professor in the department of medicine at the University of Alberta.
If a patient shows signs of heart weakening, chemotherapy is halted — sometimes for one or two months — until heart function returns to normal, he explained.
“We are aiming for two outcomes for these patients — we’re hoping to prevent heart failure and we’re hoping for them to receive all the chemotherapy that they are meant to get, when they are supposed to get it — to improve their odds of remission and survival,” Paterson said in the news release.
He also noted that heart failure often causes fatigue, shortness of breath or even death, making it “an equally devastating disease with worse prognosis than breast cancer.”
The findings were to be presented Wednesday at the San Antonio Breast Cancer Symposium. Findings presented at meetings are generally viewed as preliminary until they’ve been published in a peer-reviewed journal.
More information
The U.S. National Cancer Institute has more about breast cancer treatment.
Source: HealthDay
Copyright © 2024 HealthDay. All rights reserved.